© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filings
| Filing date | Form | Description | View |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate event |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
| S-3ASR | S-3ASR |
View HTML | |
| 424B5 | Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
| 144 | Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing |
View HTML |
Data provided by Kaleidoscope.